Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiology Journal
ISSN 1897-5593 · eISSN 1898-018X · Via Medica · POLAND · Bimonthly · Founded 2007
Cardiology Journal: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 1.85; fully open access; APC about USD 1,500; median 192 days to acceptance (102 articles, last 24 months); community-reported acceptance: easy; 116 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cardiology Journal is published by Via Medica and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics and Atrial Fibrillation Management and Outcomes, together about 26.6% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Cardiology Journal is a peer-reviewed journal published since 1994 and over the years it has become an internationally acknowledged journal, mostly due to constantly increasing quality of original papers submitted to the journal from all-over-the-world.The Journal publishes only high-quality research and review articles, letters to the editors, technology notes, images in cardiovascular medicine, editorial comments, brief communications and study protocols, comprising both clinical and translational investigations in the field of cardiology. The scope of the Journal covers a broad spectrum of topics in the field of cardiovascular medicine comprising clinical cardiology, heart failure, prevention and rehabilitation, innovation and technology, interventional cardiology, invasive/non-invasive imaging, device failure, arrhythmology, translational research, quality and outcomes.Cardiology journal is particularly focused on innovation and technology applied to cardiovascular medicine. Original Research on this topic will receive absolute priority, provided that the quality of the manuscript meets the high standards of the journal and can compete fairly with the submissions in other areas. The ultimate mission of the journal is building bridges between technology and clinical research that can be beneficial for patients with cardiovascular disease. In this context, the journal offers Ultrafast review (as explained in the authors’ guidelines) for the following categories of papers in cardiovascular research: Methodological papers. First-in-man studies of novel devices. Original research on device failure. Bioengineering models. Innovation and technology in the pipeline.
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS
Editor-in-chief Milosz J. JaguszewskiPublisher website
Editorial board by country: 3 in mainland China (about 2%); most named Poland 65, United States 11, Italy 8, Spain 8, United Kingdom 7 (128 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Coronary Interventions and DiagnosticsMedicine9.8%
- Cardiac Imaging and DiagnosticsMedicine8.5%
- Atrial Fibrillation Management and OutcomesMedicine8.4%
- Cardiovascular Function and Risk FactorsMedicine7.1%
- Cardiac Valve Diseases and TreatmentsMedicine7.1%
- Acute Myocardial Infarction ResearchMedicine6.5%
- Cardiac Arrhythmias and TreatmentsMedicine6.4%
- Cardiac pacing and defibrillation studiesMedicine6.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, CNKI, OCLC, Crossref, International Committee of Medical Journal Editors (ICMJE), Arianta, CNKI (China National Knowledge Index), Free Medical Journals (Geneva Foundation), Polska Scientific Bibliography / Polindex, Polska Bibliografia Naukowa (PBN), Polish Medical Library (GBL), ROAD (Directory of Open Access Scholarly Resources), Urlichs' Periodicals Directory, WorldCat (OCLC), SJR (Scimago Journal & Country Rank)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.85LetPub ·
- Impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 4.5LetPub ·
- CiteScore (publisher)
- 4.5Publisher website ·
- SJR 2026-06
- 0.68LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 29LetPub ·
- h-index
- 50OpenAlex ·
- i10-index
- 633OpenAlex ·
- 2-year mean citedness
- 1.05OpenAlex ·
- Self-citation rate
- 5.3%LetPub ·
- Share of gold OA articles
- 98.78%LetPub ·
Volume
- Articles per year
- 75LetPub ·
Articles by year OpenAlex count · 1,975 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 48 | 48 | 3 |
| 2025 | 116 | 116 | 86 |
| 2024 | 78 | 78 | 166 |
| 2023 | 93 | 93 | 458 |
| 2022 | 120 | 120 | 711 |
| 2021 | 176 | 176 | 1,413 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
192 daysMedian, submission to acceptance · P25–P75 115 days – 292 days
- Acceptance to online
- median 38 days (42 articles)
- Submission to online
- median 322 days
- Sample
- 102 articles with submission and acceptance dates (172 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,500 | No | CC BY-NC-ND | |
| OpenAlex | USD 900 | — | — | |
| LetPub | USD 1,200 | No | — | |
| Publisher website | EUR 1,500 / EUR 800 / EUR 500 | — | — |
Other charges and waivers (author guidelines)
- Page charges
- EUR 1,500
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Cover letter
- Required
Policy excerpts from the journal's websiteLicense & copyright, Open access, Peer review
- License & copyright Copyright Notice
Copyright transfer to publisher upon acceptance. Model summary
Completion of the online submission form electronically is tantamount to automatically and free-of-charge transferring of the copyright for publishing and distribution of the submitted material (in all known now and developed in the future forms and fields of exploitation) to the Publisher, under condition that those materials are accepted for publication. The authors agree not to publish any data…
Source ↗Publisher website ·- Open access Open Access Policy
This journal provides immediate open access to its on line content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Articles published in open access are available under Creative Common Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as…
Source ↗Publisher website ·- Peer review Peer Review Process
Follows ICMJE editorial recommendations. Model summary
Review process and manuscript selection″Cardiology Journal″ is committed to prompt evaluation and publication of submitted articles. All manuscripts together with supplementary files should be submitted online at www.cardiologyjournal.org. The submission and review process is fully electronic and submissions by e-mail or postal mail will not be accepted. Please follow the manuscript preparation di…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Via Medica
- Country or region
- POLAND
- Language
- English, Polish
- Frequency
- Bimonthly
- Founded
- 2007
- ISSN
- 1897-5593
- Electronic ISSN
- 1898-018X
- Latest issue on the website
- Volume 33 (2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cardiology Journal
What CAS zone is Cardiology Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardiology Journal is in Zone 3 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardiology Journal?
The latest impact factor listed by LetPub is 1.85; CiteScore 4.5, h-index 50.
How long does peer review take at Cardiology Journal?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 192 days (interquartile range 115–292 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Cardiology Journal based?
Of the 128 board members whose country the journal's board page names, 3 (about 2%) are in mainland China; the countries named most often are Poland (65), United States (11) and Italy (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardiology Journal?
According to LetPub and DOAJ records, Cardiology Journal is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is Cardiology Journal open access, and what is the APC?
Cardiology Journal is a fully open-access journal. APC about USD 1,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .